Walleye Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-105,335
| Closed | -$4.74M | – | 2540 |
|
|
2024
Q3 | $4.74M | Buy |
+105,335
| New | +$4.74M | 0.01% | 458 |
|
|
2024
Q2 | – | Sell |
-134,114
| Closed | -$3.88M | – | 2902 |
|
|
2024
Q1 | $3.88M | Sell |
134,114
-51,312
| -28% | -$1.48M | 0.01% | 535 |
|
|
2023
Q4 | $4.25M | Buy |
185,426
+51,610
| +39% | +$1.18M | 0.01% | 405 |
|
|
2023
Q3 | $2.23M | Buy |
133,816
+81,155
| +154% | +$1.35M | 0.01% | 622 |
|
|
2023
Q2 | $1.45M | Sell |
52,661
-74,709
| -59% | -$2.06M | 0.01% | 608 |
|
|
2023
Q1 | $2.93M | Sell |
127,370
-396,932
| -76% | -$9.13M | 0.04% | 411 |
|
|
2022
Q4 | $5.72M | Buy |
524,302
+421,359
| +409% | +$4.6M | 0.1% | 230 |
|
|
2022
Q3 | $868K | Sell |
102,943
-154,414
| -60% | -$1.3M | 0.02% | 793 |
|
|
2022
Q2 | $2.04M | Buy |
257,357
+223,967
| +671% | +$1.77M | 0.06% | 353 |
|
|
2022
Q1 | $791K | Sell |
33,390
-64,608
| -66% | -$1.53M | 0.02% | 724 |
|
|
2021
Q4 | $3.35M | Buy |
97,998
+87,882
| +869% | +$3.01M | 0.1% | 201 |
|
|
2021
Q3 | $179 | Buy |
+10,116
| New | +$179 | 0.01% | 1188 |
|